XM tillhandahåller inte tjänster till personer bosatta i USA.

EMFX unlikely to reverse 2024 losses over the next six months



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>RPT-POLL-EMFX unlikely to reverse 2024 losses over the next six months</title></head><body>

Repeats earlier story for wider readership with no change to text

By Vuyani Ndaba and Devayani Sathyan

JOHANNESBURG/BENGALURU, July 3 (Reuters) -Emerging market currencies will not reverse this year's losses against a resilient dollar in the next six months as China's economy struggles and the U.S. Federal Reserve holds back on interest rate cuts, according to a Reuters poll.

With the Fed not expected to cut rates as many times as financial markets had predicted at the beginning of the year, from around six then to just two now, that has left most emerging currencies vulnerable against a strong dollar.

Federal Reserve Chair Jerome Powell said on Tuesday that although the U.S. was back on a "disinflationary path" policymakers will need more data before they start cutting interest rates.

The dollar index .DXY is up 4.3% this year and was predicted to stay strong in the near term. EUR/POLL

Almost all emerging market currencies surveyed were forecast to not recoup the losses already made this year in the next three to six months, according to the June 28-July 3 survey of over 58 foreign exchange strategists.

China's troubled property sector is likely to weigh heavily on the economic and currency performance in the world's second-biggest economy, boding ill for the performance of other emerging market currencies. It remains the single biggest trading partner to many nations.

"We look for more depreciation of the yuan and Chinese growth is unlikely to pick up significantly in the months ahead, that also means less upside for the rest of Asia," said Mitul Kotecha, head of FX & EM macro strategy Asia at Barclays.

The tightly controlled Chinese yuan CNY= is expected to gain 0.3% by the end of 2024,after dropping 2.4% against the greenback so far this year.

"The overall outlook is still for more downside pressure in the next three to six months for EM currencies. Broadly the two main factors that will drive EM currencies continues to be dollar strength and relatively high U.S. rates," Kotecha added.

This is despite a small loss of around 1% in the emerging market currency index .MIEM00000CUS in which the yuan plays a big part.

China's economy was expected to drive EM currencies into gains at the start of this year when its economy opened wider after strict COVID-19 restrictions were relaxed.

Some major EM currencies such as the Indonesian rupiah IDR=, Korean won KRW=, Thai Bhat THB=, Singapore dollar SGD=, Taiwan dollar TWD= and Philippine peso PHP= were expected to gain between 1%-3% by the end of the year.

However, those gains would still be minuscule compared to the losses this year to date.

The Indian rupee INR=, which has stood out as the most stable among EM currencies, is set to trade within a narrow range over the year. INR/POLL

South Africa's rand ZAR=D3, is predicted to gain 2.8% in six months after a loss of about 1% in the first half.

The key to the rand outlook will be the U.S. interest rate cut timing, with markets still expecting with certainty the first cut in November, Annabel Bishop, chief economist at Investec wrote in a note.

Since national elections in late May when President Cyril Ramaphosa's African National Congress party lost its majority for the first time in three decades the rand has been very volatile.

The Russian rouble RUB= is expected to lose around 7.5% to 95.00 to the dollar while the Turkish lira TRY= will weaken nearly 10% to 36.09 to the dollar in the next six months.


(For other stories from the July Reuters foreign exchange poll: nL4N3IM0R6)



Reporting by Vuyani Ndaba and Devayani Sathyan; Polling by Veronica Khongwir, Susobhan Sarkar, Arun Purujit, Rahul Trivedi and Pranoy Krishna; Editing by Jonathan Cable and Christian Schmollinger

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.